Article Information
PubMed
Published By
History
- Received December 12, 2009
- Revision received January 28, 2010
- Accepted February 3, 2010
- First published March 10, 2010.
- Version of record published March 10, 2010.
Copyright & Usage
Copyright © 2010 the authors 0270-6474/10/303777-05$15.00/0
Author Information
- Jong H. Yoon1,
- Richard J. Maddock1,
- Ariel Rokem2,
- Michael A. Silver2,
- Michael J. Minzenberg1,
- J. Daniel Ragland1, and
- Cameron S. Carter1
- 1Department of Psychiatry and Imaging Research Center, University of California, Davis, Davis, California 95817, and
- 2School of Optometry and Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California 94720
- Correspondence should be addressed to Jong H. Yoon, Imaging Research Center, University of California, Davis, 4701 X Street, Sacramento, CA 95817. jhyyoon{at}ucdavis.edu
Author contributions
Disclosures
- Received December 12, 2009.
- Revision received January 28, 2010.
- Accepted February 3, 2010.
-
This study has been funded by the National Alliance for Research on Schizophrenia and Depression Foundation and National Institutes of Health/National Institute of Mental Health.
-
C.S.C. has been a paid consultant for Merck, Eli Lilly and Co., and Roche. R.J.M. has been a paid consultant for Pfizer.
- Correspondence should be addressed to Jong H. Yoon, Imaging Research Center, University of California, Davis, 4701 X Street, Sacramento, CA 95817. jhyyoon{at}ucdavis.edu
Online Impact